At a glance
- Originator Toa Eiyo
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 30 Dec 1994 Discontinued-Phase-Unspecified for Rheumatic disorders (Unspecified route)